bio scope technologies ltd Company Information
Company Number
13876617
Next Accounts
Sep 2025
Industry
Recovery of sorted materials
Shareholders
bio scope 3 ltd
Group Structure
View All
Contact
Registered Address
eldo house kempson way, bury st. edmunds, suffolk, IP32 7AR
Website
-bio scope technologies ltd Estimated Valuation
Pomanda estimates the enterprise value of BIO SCOPE TECHNOLOGIES LTD at £1.7m based on a Turnover of £2.8m and 0.6x industry multiple (adjusted for size and gross margin).
bio scope technologies ltd Estimated Valuation
Pomanda estimates the enterprise value of BIO SCOPE TECHNOLOGIES LTD at £0 based on an EBITDA of £-1.5m and a 4.01x industry multiple (adjusted for size and gross margin).
bio scope technologies ltd Estimated Valuation
Pomanda estimates the enterprise value of BIO SCOPE TECHNOLOGIES LTD at £0 based on Net Assets of £-2.7m and 2.47x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bio Scope Technologies Ltd Overview
Bio Scope Technologies Ltd is a live company located in suffolk, IP32 7AR with a Companies House number of 13876617. It operates in the recovery of sorted materials sector, SIC Code 38320. Founded in January 2022, it's largest shareholder is bio scope 3 ltd with a 100% stake. Bio Scope Technologies Ltd is a startup, small sized company, Pomanda has estimated its turnover at £2.8m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Bio Scope Technologies Ltd Health Check
Pomanda's financial health check has awarded Bio Scope Technologies Ltd a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 8 areas for improvement. Company Health Check FAQs
0 Strong
2 Regular
8 Weak
Size
annual sales of £2.8m, make it smaller than the average company (£13.9m)
- Bio Scope Technologies Ltd
£13.9m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Bio Scope Technologies Ltd
- - Industry AVG
Production
with a gross margin of 22.8%, this company has a comparable cost of product (22.8%)
- Bio Scope Technologies Ltd
22.8% - Industry AVG
Profitability
an operating margin of -62.4% make it less profitable than the average company (6.1%)
- Bio Scope Technologies Ltd
6.1% - Industry AVG
Employees
with 17 employees, this is below the industry average (35)
17 - Bio Scope Technologies Ltd
35 - Industry AVG
Pay Structure
on an average salary of £39.4k, the company has an equivalent pay structure (£39.4k)
- Bio Scope Technologies Ltd
£39.4k - Industry AVG
Efficiency
resulting in sales per employee of £167.1k, this is less efficient (£349.5k)
- Bio Scope Technologies Ltd
£349.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Bio Scope Technologies Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 6 days, this is quicker than average (33 days)
- Bio Scope Technologies Ltd
33 days - Industry AVG
Stock Days
it holds stock equivalent to 41 days, this is more than average (17 days)
- Bio Scope Technologies Ltd
17 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (13 weeks)
0 weeks - Bio Scope Technologies Ltd
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 257.3%, this is a higher level of debt than the average (51.7%)
257.3% - Bio Scope Technologies Ltd
51.7% - Industry AVG
BIO SCOPE TECHNOLOGIES LTD financials
Bio Scope Technologies Ltd's latest turnover from December 2023 is estimated at £2.8 million and the company has net assets of -£2.7 million. According to their latest financial statements, Bio Scope Technologies Ltd has 17 employees and maintains cash reserves of £19.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | |
---|---|---|
Turnover | ||
Other Income Or Grants | ||
Cost Of Sales | ||
Gross Profit | ||
Admin Expenses | ||
Operating Profit | ||
Interest Payable | ||
Interest Receivable | ||
Pre-Tax Profit | ||
Tax | ||
Profit After Tax | ||
Dividends Paid | ||
Retained Profit | ||
Employee Costs | ||
Number Of Employees | 17 | 7 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | |
---|---|---|
Tangible Assets | 1,277,837 | 968,811 |
Intangible Assets | 0 | 0 |
Investments & Other | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 |
Total Fixed Assets | 1,277,837 | 968,811 |
Stock & work in progress | 248,230 | 112,856 |
Trade Debtors | 0 | 0 |
Group Debtors | 0 | 0 |
Misc Debtors | 167,480 | 245,313 |
Cash | 19,073 | 133,160 |
misc current assets | 0 | 0 |
total current assets | 434,783 | 491,329 |
total assets | 1,712,620 | 1,460,140 |
Bank overdraft | 0 | 0 |
Bank loan | 0 | 0 |
Trade Creditors | 36,264 | 108,182 |
Group/Directors Accounts | 4,044,787 | 2,130,225 |
other short term finances | 0 | 0 |
hp & lease commitments | 0 | 0 |
other current liabilities | 326,285 | 146,339 |
total current liabilities | 4,407,336 | 2,384,746 |
loans | 0 | 0 |
hp & lease commitments | 0 | 0 |
Accruals and Deferred Income | 0 | 0 |
other liabilities | 0 | 0 |
provisions | 0 | 0 |
total long term liabilities | 0 | 0 |
total liabilities | 4,407,336 | 2,384,746 |
net assets | -2,694,716 | -924,606 |
total shareholders funds | -2,694,716 | -924,606 |
Dec 2023 | Dec 2022 | |
---|---|---|
Operating Activities | ||
Operating Profit | ||
Depreciation | 291,730 | 84,715 |
Amortisation | 0 | 0 |
Tax | ||
Stock | 135,374 | 112,856 |
Debtors | -77,833 | 245,313 |
Creditors | -71,918 | 108,182 |
Accruals and Deferred Income | 179,946 | 146,339 |
Deferred Taxes & Provisions | 0 | 0 |
Cash flow from operations | ||
Investing Activities | ||
capital expenditure | ||
Change in Investments | 0 | 0 |
cash flow from investments | ||
Financing Activities | ||
Bank loans | 0 | 0 |
Group/Directors Accounts | 1,914,562 | 2,130,225 |
Other Short Term Loans | 0 | 0 |
Long term loans | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 |
other long term liabilities | 0 | 0 |
share issue | ||
interest | ||
cash flow from financing | ||
cash and cash equivalents | ||
cash | -114,087 | 133,160 |
overdraft | 0 | 0 |
change in cash | -114,087 | 133,160 |
bio scope technologies ltd Credit Report and Business Information
Bio Scope Technologies Ltd Competitor Analysis
Perform a competitor analysis for bio scope technologies ltd by selecting its closest rivals, whether from the WATER SUPPLY; SEWERAGE, WASTE MANAGEMENT AND REMEDIATION ACTIVITIES sector, other small companies, companies in IP32 area or any other competitors across 12 key performance metrics.
bio scope technologies ltd Ownership
BIO SCOPE TECHNOLOGIES LTD group structure
Bio Scope Technologies Ltd has no subsidiary companies.
bio scope technologies ltd directors
Bio Scope Technologies Ltd currently has 3 directors. The longest serving directors include Mr Jack Gomarsall (Jan 2022) and Mr Nicholas Razey (Jan 2024).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Jack Gomarsall | United Kingdom | 78 years | Jan 2022 | - | Director |
Mr Nicholas Razey | 63 years | Jan 2024 | - | Director | |
Mr Jeff Borrman | United Kingdom | 66 years | Jan 2024 | - | Director |
P&L
December 2023turnover
2.8m
+72%
operating profit
-1.8m
0%
gross margin
22.8%
-4.76%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-2.7m
+1.91%
total assets
1.7m
+0.17%
cash
19.1k
-0.86%
net assets
Total assets minus all liabilities
Similar Companies
bio scope technologies ltd company details
company number
13876617
Type
Private limited with Share Capital
industry
38320 - Recovery of sorted materials
incorporation date
January 2022
age
3
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
KNIGHTS LOWE LIMITED
auditor
-
address
eldo house kempson way, bury st. edmunds, suffolk, IP32 7AR
Bank
-
Legal Advisor
-
bio scope technologies ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bio scope technologies ltd.
bio scope technologies ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIO SCOPE TECHNOLOGIES LTD. This can take several minutes, an email will notify you when this has completed.
bio scope technologies ltd Companies House Filings - See Documents
date | description | view/download |
---|